FDA Approves First Pill to Treat Moderate-to-Severe Crohn Disease
In clinical trials, more patients taking Rinvoq achieved remission and reduced intestinal inflammation compared with patients given a placebo
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.